Literature DB >> 3713587

Gallstone pancreatitis.

A M Bell, M G O'Rourke.   

Abstract

Gallstone pancreatitis is a disease of high mortality (11%) and significant morbidity (42%). An analysis of 66 patients with this disease revealed the importance of an early aetiological diagnosis; 66% of our patients had evidence of previous biliary disease. Most patients were elderly and the severity of their disease could be predicted using Ranson's predictive indices. Surgery was immediate (within 48 hours) in 11 (17%) patients, early (two-14 days) in 16 (24%) and delayed in 27 (41%) patients. Some patients refused surgery. Our study suggests that very ill patients require immediate surgery--often cholecystostomy alone--and that although in the majority symptoms should settle on conservative treatment, definitive surgery should be carried out at the time of the initial admission. Further delay increases morbidity, mortality and expense.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713587     DOI: 10.5694/j.1326-5377.1986.tb112312.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  Detection of biliary origin of acute pancreatitis. Comparison of laboratory tests, ultrasound, computed tomography, and ERCP.

Authors:  J Schölmerich; V Gross; T Johannesson; G Brobmann; K Rückauer; B Wimmer; W Gerok; E H Farthmann
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

2.  Pancreatitis from intestinal reflux--again?

Authors:  M Blackstone
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

3.  Gallstone pancreatitis: does discharge and readmission for cholecystectomy affect outcome?

Authors:  L K McCullough; F R Sutherland; R Preshaw; S Kim
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

4.  Acute gallstone pancreatitis: a constant challenge for the surgeon.

Authors:  T S Papavramidis; N Zandes; K Hatzimisios; Th Koutsimani; F Kehagia; P Agorastou; M Doulgerakis; I Patoulidis
Journal:  Indian J Surg       Date:  2008-11-26       Impact factor: 0.656

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.